Literature DB >> 7238452

Distinct enzymatic responses in mice exposed to a range of low doses of ozone.

T S Veninga, J Wagenaar, W Lemstra.   

Abstract

Short-term exposure of mice to low O3 doses, as defined by the product of concentration and exposure time (ct), was observed to induce alterations in two enzyme systems: first, that leading to changes in hepatic reduced ascorbic acid (RAA) content, and second to changes in plasma creatine phosphokinase (CPK) activity. RAA alterations were noticed immediately, 30 min and 120 min after termination of the exposure period, whereas CPK showed alterations immediately and 15 min after termination of the exposure. Later determinations, i.e., 24 hr after O3 exposure for RAA and 30 min after 03 exposure for CPK, revealed no significant differences when compared to control animals. Although differences in sensitivity existed, the dose response curves for both systems were more or less similar, showing a short decrease for the initial very low O3 doses, followed by a profound rise and a gradual decrease to control levels for subsequent ct doses. Exceptions were the 30 min curve for RAA and the immediate curve for CPK in so far as that both showed an additional depression. Neither plasma histamine nor plasma lactic acid dehydrogenase (LDH3) were observed to be altered by the range of O3 doses employed. These findings were explained on the basis of adaptation of the organism to a potentially noxious O3 stimulus by enhanced metabolic processes: a weak stimulus leading to only a small adjustment, and stronger stimuli to elevated enzyme activity as well. With increasing doses of O3 this elevation in enzyme activity was found to be gradually diminished, possibly due to a steadily growing demand, leaving the overshoot becoming continually smaller until a balanced state is achieved.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7238452      PMCID: PMC1568736          DOI: 10.1289/ehp.8139153

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  20 in total

1.  Detection of pulmonary irradiation injury by determining plasma lactic dehydrogenase (LDH) activity.

Authors:  C M Bloor; E P Leroy; P J Friedman; B E Sobel
Journal:  Radiat Res       Date:  1974-02       Impact factor: 2.841

2.  Ozone as a possible radiomimetic gas.

Authors:  R BRINKMAN; H B LAMBERTS
Journal:  Nature       Date:  1958-04-26       Impact factor: 49.962

3.  Biochemical responses in lungs of ozone-tolerant rats.

Authors:  C K Chow
Journal:  Nature       Date:  1976-04-22       Impact factor: 49.962

4.  Pathology of pulmonary disease from exposure to interdependent ambient gases (nitrogen dioxide and ozone).

Authors:  G Freeman; L T Juhos; N J Furiosi; R Mussenden; R J Stephens; M J Evans
Journal:  Arch Environ Health       Date:  1974-10

Review 5.  Ozone and lipid peroxidation.

Authors:  B D Goldstein; C Lodi; C Collinson; O J Balchum
Journal:  Arch Environ Health       Date:  1969-04

6.  An enzymatic protective mechanism against lipid peroxidation damage to lungs of ozone-exposed rats.

Authors:  C K Chow; A L Tappel
Journal:  Lipids       Date:  1972-08       Impact factor: 1.880

7.  Modification of the enzymatic isotopic assay of histamine and its application to measurement of histamine in tissues, serum and urine.

Authors:  M A Beaven; S Jacobsen; Z Horáková
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

8.  Effects of ozone exposure in Canadians and Southern Californians. Evidence for adaptation?

Authors:  J D Hackney; W S Linn; S K Karuza; R D Buckley; D C Law; D V Bates; M Hazucha; L D Pengelly; F Silverman
Journal:  Arch Environ Health       Date:  1977 May-Jun

9.  Effect of ozone on lipid peroxidation in the red blood cell.

Authors:  B D Goldstein; O J Balchum
Journal:  Proc Soc Exp Biol Med       Date:  1967-11

10.  Effects of NO2 on chronic bronchitics.

Authors:  G von Nieding; H M Wagner
Journal:  Environ Health Perspect       Date:  1979-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.